Trying to broaden the review perspective
The purpose of this series of posts is to examine some human clinical trials of medications intended to improve behavior and cognition in Fragile X Syndrome.
Summaries of several of these clinical trials have already been published. For example, a review with tables of various clinical tests used during several FXS drug trials can be found in:
Sébastien Jacquemont, Elizabeth Berry-Kravis, Randi Hagerman, Florian von Raison, Fabrizio Gasparini, George Apostol, Mike Ufer, Vincent Des Portes & Baltazar Gomez-Mancilla, Psychopharmacology (2014) 231:1237–1250 DOI 10.1007/s00213-013-3289-0. LINK